Shape 21 Experience
    AACC 2020

    Siemens Healthineers 2020 AACC Scientific Posters

    Our scientific posters cover relevant topics that represent Siemens Healthineers breadth of menu, from innovative assay studies to performance evaluations of our laboratory and point-of-care testing solutions.

    A-043 Performance Evaluation of the ADVIA® Chemistry Systems Enzymatic Hemoglobin A1c_E Calibrator

    Wilkins G, Robinson C, Gisiora J, Jones J, Hixson C.
    Siemens Healthcare Diagnostics Inc., Newark, DE, USA

    A-055 Stable Unconjugated Bilirubin Solution: Potential Usage as Calibrators and Controls

    Chakraborty I1, Galgalkar S1, Ledden D2.
    1Siemens Healthcare Pvt Ltd, Bangalore, India
    2Siemens Healthcare Diagnostics Inc., Mishawaka, IN, USA

    A-107 Evaluation of Harmonization across Siemens Healthineers Current Blood Gas and Clinical Chemistry Systems for All Common Analytes

    Shum S, Umscheid T, Fennell S.
    Siemens Healthcare Diagnostics Inc. Norwood, MA, USA

    A-153 Analytical and Clinical Performance of the ADVIA Centaur® Anti-thyroglobulin (aTgII) Assay

    Arcuri M, Low O, Krumm C, Ray S., Dauscher C.
    Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA

    A-154 Performance Evaluation of the Atellica IM Thyroglobulin (Tg) Assay

    Schiavoni L, Bradley K, Carbone L, Higgins C, Iaconelli E, St-Onge S, Yang Y, Zhao Z, Dauscher C.
    Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA

    A-238 Evaluation of Assay Performance in Cadaver (Organ Donor) Subjects for ADVIA Centaur Infectious Disease Assays

    Wright T1, Patibandla S1, Walsh R1, Fonstad R1, Gee M1, Bitcon V1, Brendle J1, Hopper J1, Degenu P1, Braniff S2, Best S2, Read S3.
    1 Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA
    2 National Serology Reference Laboratory (NRL) Australia, Victoria, Australia
    3 Siemens Healthcare Pty Ltd., Victoria, Australia

    A-240 Performance Evaluation of the ADVIA Centaur and Atellica® CMV IgM Assays*

    Shin S, Stadnick II R, Son M, Cusack P, Karpiej M, Paden K, Vyas V, Patibandla S.
    Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA

    A-345 Development of B.R.A.H.M.S Procalcitonin Assay Using LOCI® Technology on the Dimension® EXL Integrated Chemistry System*

    Kelly K, Schaible C, Tyler A, Israel B, Wei T.
    Siemens Healthcare Diagnostics Inc., Newark, DE, USA

    B-098 Performance Evaluation of the INNOVANCE® Free PS Ag Assay on the Sysmex® CS-5100, Sysmex CS-2500 and the BCS® XP Systems

    Morowski M1, Lange S2, Doimo A1, Hod EA3, Francis JL4, Marchant KK5, Merz M1.
    1 Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany
    2 Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA
    3 Columbia University Medical Center, New York, NY, USA
    4 Florida Hospital Center for Thrombosis Research, Winter Park, FL, USA
    5 Cleveland Clinic, Cleveland, OH, USA

    B-102 Interference of the direct Factor Xa inhibitors Rivaroxaban and Apixaban in the determination of FVIII using Dade® Actin® FS and Dade Actin FSL reagents

    Pahren D, Wilkens M, Morowski M, Merz M, Schobel U.
    Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany

    B-152 Performance Evaluation of the Atellica CH Trig_2 Assay*

    Blagovcanin D, Cheek J, Sinopoli A, Estock K.
    Siemens Healthineers, Newark, DE, USA

    B-239 Performance Evaluation of the Atellica CH HIL feature

    Snyder JT, Garcia E, Davis J, Cheek J.
    Siemens Healthcare Diagnostics Inc., Newark, DE, USA

    B-240 Performance Evaluation of Sample Carryover on the Atellica CH Analyzer

    Koellhoffer J, Snyder JT, Cheek J.
    Siemens Healthcare Diagnostics Inc., Newark, DE, USA

    B-313 Performance Evaluation of the N Latex Free Light Chains (Kappa and Lambda) on the Atellica CH Analyzer

    Muth D, Ehm M, Schwarz K.
    Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany

    A-101 Performance Evaluation of Glycated Hemoglobin Assay on Different Analytical Platforms

    Elida Serregatti¹, Francine Meyrer¹, Luiza Katsue Kikuchi¹, Hélida Patricia de Oliveira Silva²
    1 SLAB Laboratórios
    2 Siemens Healthineers, São Paulo, Brazil

    A-062 Performance Evaluation of the Atellica CH Enzymatic Hemoglobin A1c Assay on the Atellica CH Analyzer and Comparison with the Sebia CAPILLARYS 2 FLEX PIERCING Instrument

    C. Medel1, M. Ollivet-Besson1, O. Peñaloza1, J. Suárez Gómez2.
    1Laboratorio Central BioNet, Santiago, Chile; 2Siemens Healthcare Equipos Médicos Sociedad por Acciones, Santiago, Chile

    B-217 Successful Conversion to a High-Sensitivity Tropinin I Assay

    Guergour D1, Chirica C1, Soreng K2.

    Central Lab Biochemistry Immunoassays, Institut de Biologie et Pathologie du CHU de Grenoble-Alpes, France.
    Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA
    To view posters, visit www.aacc.org
    *Under development. Not available for sale. The performance characteristics of this product have not been established.
    ±Under development. Not available for sale. Features listed are development design goals. Future availability cannot be guaranteed.
    Products with cadaveric claims are under development and not available for sale.
    Product availability may vary by country and is subject to local regulatory requirements.